Accenture stock upgraded as analyst sees accelerating growth trajectory into FY26 By Investing.com

On Monday, TD Cowen increased its rating on shares of Accenture plc (NYSE:) from Hold to Buy, also raising the price target to $400 from $321. The adjustment reflects the analyst’s optimism about the company’s prospects as it moves into fiscal year 2025.

Accenture is recognized for its recent performance, with bookings surpassing expectations and the company establishing a solid base as it enters FY25. The firm’s positive trajectory is attributed to several factors, including the diminishing impact of market headwinds, the successful adoption of Generative AI, and potential demand boosts stemming from Federal Reserve rate cuts, which are likely to support IT budgets and tech stock valuations in calendar year 2025.

The upgrade by TD Cowen is not just about Accenture’s individual outlook but also represents a broader positive sentiment on the Services sector. Accenture is seen as a prime vehicle for investors seeking exposure to this sector. The company’s progress in addressing challenges as it concludes fiscal year 2024 bolsters confidence in a favorable near-term setup.

The analyst also points out that Accenture’s guidance for the first quarter and the entire FY25 suggests limited downside risk. The current market position is considered to have a protective buffer, and any bearish scenario from this point would likely require a downturn in CY25 budgets or an overvaluation of the company’s stock, which the analyst believes is unlikely.

In conclusion, the firm’s outlook is supported by anticipated improvements across multiple areas of Accenture’s business. This includes an expected acceleration of organic growth through FY26 and the belief that investors will likely position themselves favorably in the Services sector in anticipation of a demand recovery by 2025.

In other recent news, Accenture plc has demonstrated impressive financial performance with record bookings of $81 billion and revenue of $65 billion in fiscal year 2024. The company’s GenAI bookings for the quarter reached $1 billion, marking an 11% increase from the previous quarter and bringing the total GenAI bookings to $3 billion for the fiscal year. Accenture’s management expects low- to mid-single-digit growth in both consulting and managed services for fiscal year 2025, with plans to invest approximately $3 billion in acquisitions and return at least $8.3 billion to shareholders.

Analysts have varied opinions on the company’s performance. BMO Capital increased its price target for Accenture to $390, maintaining a Market Perform rating, while William Blair reiterated an Outperform rating, emphasizing the company’s leadership in developing AI capabilities. In contrast, Goldman Sachs maintained a neutral stance on Accenture shares.

InvestingPro Insights

Accenture’s strong market position, as highlighted by TD Cowen’s upgrade, is further supported by data from InvestingPro. The company’s market capitalization stands at an impressive $219.05 billion, underscoring its significant presence in the IT Services industry. This aligns with the InvestingPro Tip that Accenture is a “prominent player in the IT Services industry.”

The company’s financial health appears robust, with a revenue of $64.9 billion over the last twelve months as of Q4 2024. This solid revenue base supports Accenture’s ability to invest in emerging technologies like Generative AI, which TD Cowen identified as a key growth driver.

Moreover, Accenture’s dividend policy reflects its financial stability. An InvestingPro Tip notes that the company “has maintained dividend payments for 20 consecutive years,” with a current dividend yield of 1.69%. This consistent dividend history may appeal to investors looking for both growth and income in the Services sector.

For those interested in a deeper analysis, InvestingPro offers 12 additional tips on Accenture, providing a comprehensive view of the company’s financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.